Showing results (81-90 of 152) with videos related to
Sort By:
Pageof 16
Therapeutic Advances in Neurological Disorders|March 18, 2022
Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune responseCédric Hirzel, Denis Grandgirard, Bernard Surial, et al.Neurology(R) Neuroimmunology & Neuroinflammation|May 15, 2020
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosisMarie-Christine Reinert, Pascal Benkert, Jens Wuerfel, et al.Brain Communications|November 10, 2021
Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approachTianrong Yeo, Fay Probert, Megan Sealey, et al.Brain : a Journal of Neurology|June 4, 2018
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosisChristian Barro, Pascal Benkert, Giulio Disanto, et al.Critical Care (London, England)|January 21, 2021
Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective studySabina Hunziker, Adrian Quinto, Maja Ramin-Wright, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2021
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosisTomas Uher, Eva Kubala Havrdova, Pascal Benkert, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 5, 2020
White matter lesion location correlates with disability in relapsing multiple sclerosisLaura Gaetano, Baldur Magnusson, Petya Kindalova, et al.Journal of Neurology|October 31, 2023
Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extensionLudwig Kappos, Anthony Traboulsee, David K B Li, et al.European Journal of Neurology|February 13, 2023
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosisArabella Buchmann, Lukas Pirpamer, Daniela Pinter, et al.Annals of Clinical and Translational Neurology|August 23, 2019
Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal studyDejan Jakimovski, Jens Kuhle, Murali Ramanathan, et al.Pageof 16